THC Loaded Into a Vaporizer Was Not the Same as THC Absorbed by Each Patient

The prescribed-flower study estimated THC from product strength and weighed flower, while warning that this was not each participant’s absorbed dose. The distinction matters when comparing cognitive effects with milligrams on a study table.

The nominal calculation used material and strength

Participants weighed prescribed flower for vaporization. The paper calculated a mean nominal THC amount of 48.49 mg from the flower’s weight and stated potency. This was an estimate of THC represented in the material, not a measured systemic amount.

Administration introduced additional variation

Participants consumed different numbers of balloons, and vaporizer temperatures varied. Inhalation technique, delivery efficiency and absorption also affected exposure. The authors explicitly cautioned that the calculation did not fully account for these factors. A large nominal value should not be treated as an intravenous-equivalent amount.

Exposure-response comparisons need compatible quantities

A comparison with an oral dose or another inhalation study must preserve whether the number refers to loaded, delivered or absorbed drug. A nominal dose can help describe the protocol without locating a participant on a precise blood concentration-effect curve. This uncertainty does not erase the observed cognitive findings, but limits assigning them a universal milligram threshold. It also prevents a study-average amount from becoming a dosing recommendation or an individualized impairment rule.

Related analysis: the study’s main findings and limitations.

Research cited

Stefanidis and colleagues. Elucidating the acute effects of medically prescribed oral and vaporised delta-9-tetrahydrocannabinol on cognitive functions important for driving. Drug and Alcohol Review (2025). DOI: 10.1111/dar.14060.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

CBD Memory Findings in Cerebral-Malaria Mice Involved Adjunctive Antimalarial Treatment

A mouse cerebral-malaria experiment summarized in the CBD brain review reported memory findings when CBD was added to artesunate. The observation concerned adjunctive treatment in an infectious-disease model, rather than CBD alone as a general memory enhancer. The disease and co-treatment belonged in the result The review describes CBD treatment…

Spread the love

Read Article: CBD Memory Findings in Cerebral-Malaria Mice Involved Adjunctive Antimalarial Treatment

Serotonin Blockade Qualified CBD Pain Mechanisms Differently Across Rat Models

Rat experiments summarized in the CBD brain review found different degrees of interference with CBD-related pain responses after serotonin-receptor blockade. The evidence did not establish one exclusive mechanism for every model. The diabetic and nerve-injury models differed In male diabetic rats, the review reports attenuation of mechanical allodynia with CBD…

Spread the love

Read Article: Serotonin Blockade Qualified CBD Pain Mechanisms Differently Across Rat Models

Attrition and Incomplete Dosing Complicated an Observational CBD Pain Report

An observational CBD study summarized in the brain-function review reported improvement in pain patients but had substantial participant loss and incomplete dosing information. Those limitations constrained attribution of the change to CBD. The clinical groups did not report one uniform response The review describes Gulbransen and colleagues’ exploratory quality-of-life study….

Spread the love

Read Article: Attrition and Incomplete Dosing Complicated an Observational CBD Pain Report

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us